
BATTAGLINI MARCO
Marco
Battaglini
Ricercatore Legge 240/10 - tempo determinato
Contacts
Teaching activities
Completion accademic year: 2021/2022
Completion accademic year: 2020/2021
Research
Ultime pubblicazioni:
- Pagani, E., Storelli, L., Pantano, P., Petsas, N., Tedeschi, G., Gallo, A., et al. (2023). Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis. JOURNAL OF NEUROLOGY, 270(1), 446-459 [10.1007/s00415-022-11387-2]. - view more
- Cortese, R., Battaglini, M., Pia Sormani, M., Luchetti, L., Gentile, G., Inderyas, M., et al. (2023). Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets. EUROPEAN JOURNAL OF NEUROLOGY, 30(1), 179-186 [10.1111/ene.15579]. - view more
- Cortese, R., Battaglini, M., Prados, F., Bianchi, A., Haider, L., Jacob, A., et al. (2022). Clinical and MRI measures to identify non-acute MOG-antibody disease in adults. BRAIN [10.1093/brain/awac480]. - view more
- De Stefano, N., Battaglini, M., Pareto, D., Cortese, R., Zhang, J., Oesingmann, N., et al. (2022). MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies. NEUROIMAGE. CLINICAL, 34, 102972 [10.1016/j.nicl.2022.102972]. - view more
- Battaglini, M., Vrenken, H., Tappa Brocci, R., Gentile, G., Luchetti, L., Versteeg, A., et al. (2022). Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta-1a. EUROPEAN JOURNAL OF NEUROLOGY, 29(7), 2024-2035 [10.1111/ene.15314]. - view more